Full history for every metric is available with a Kvantra account
Rockley Photonics Holdings Limited (RKLY)
Key financial summary
Financials in USD| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | TTM | ||
|---|---|---|---|---|---|---|---|---|
| Total revenue | $m | - | - | - | 22 | 8 | 3 | 3 |
| Operating profit | $m | -235 | -235 | |||||
| Net profit | $m | - | - | - | -80 | -168 | -224 | -224 |
| EPS reported | $ | -1.72 | -1.76 | |||||
| Operating cashflow per share | $ | -0.97 | -0.97 | |||||
| Capex per share | $ | 0.03 | 0.03 | |||||
| FCF per share | $ | -1.00 | -1.00 | |||||
| Free cash flow | $m | -131 | -131 | |||||
| Net debt | $m | 90 | 90 | |||||
| Book value equity | $m | -99 | -99 | |||||
| Book value per share | $ | -0.76 | -0.76 | |||||
| Number of shares | m | 130.35 | 130.35 | |||||
| DPS (TTM paid) | $ | 0.00 | 0.00 |
Financial summary
Financials in USD| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | TTM | ||
|---|---|---|---|---|---|---|---|---|
| Value | ||||||||
| P/E TTM | x | - | - | |||||
| P/B LTM | x | -0.18 | -0.25 | |||||
| P/S LTM | x | 5.62 | 0.00 | |||||
| P/FCF LTM | x | -0.14 | 0.00 | |||||
| EV/EBITDA LTM | x | -0.64 | -0.53 | |||||
| EV/Sales LTM | x | 33.42 | 27.80 | |||||
| Earnings Yield LTM | % | -1226.8% | -893.34% | |||||
| FCF Yield | % | -715.45% | - | |||||
| Quality | ||||||||
| ROE | % | 225.50% | -10037.6% | |||||
| ROIC | % | -1305.6% | -1305.6% | |||||
| Operating margin | % | -7242.4% | -7242.4% | |||||
| Gross margin | % | -160.50% | -160.50% | |||||
| FCF/Sales | % | -4022.6% | -4022.6% | |||||
| Growth and momentum | ||||||||
| EPS Growth YoY | % | - | - | |||||
| Sales Growth YoY | % | -60.45% | -60.45% | |||||
| Net Income Growth YoY | % | - | - | |||||
| FCF Growth | % | - | - | |||||
| Operating Profit Growth | % | - | - | |||||
| Dividend and capital structure | ||||||||
| Dividend Yield | % | 0.00% | 0.00% | |||||
| Dividend Growth | % | 0.00% | 0.00% | |||||
| Payout Ratio | % | 0.00% | 0.00% | |||||
| FCF/Debt | x | -1.15 | -1.15 | |||||
| Net Debt/EBITDA | x | -0.53 | -0.53 | |||||
| EBIT/Net interest | x | 16.01 | 16.01 | |||||
| Net debt/market cap | % | 494.41% | - | |||||
| Net debt/Equity | x | -0.91 | -0.91 | |||||
| Gross debt/equity | x | -1.14 | -1.14 | |||||
Company overview
Rockley Photonics Holdings Limited, established in Altrincham, UK in 2013, is a global innovator specializing in the development and provision of silicon photonics technology. The company's core platform features specialized photonic integrated circuits (PICs) that incorporate III-V devices, alongside application-specific electronic integrated circuits (ASICs). These components are meticulously co-packaged and further supported by an extensive suite of technologies, including biosensing algorithms, artificial intelligence (AI), cloud-based analytics, firmware/software, sophisticated system architecture, and robust hardware design. A key application of their technology is a comprehensive biosensing platform, designed for diverse health-related purposes such as enhancing consumer wellness, continuous long-term health trend monitoring, patient oversight, early disease detection, optimizing nutrition management, and aiding in the therapeutic management of various chronic conditions.
Similar companies
For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.
Rockley Photonics Holdings Limited (RKLY)
Rockley Photonics Holdings Limited, established in Altrincham, UK in 2013, is a global innovator specializing in the development and provision of silicon photonics technology. The company's core platform features specialized photonic integrated circuits (PICs) that incorporate III-V devices, alongside application-specific electronic integrated circuits (ASICs). These components are meticulously co-packaged and further supported by an extensive suite of technologies, including biosensing algorithms, artificial intelligence (AI), cloud-based analytics, firmware/software, sophisticated system architecture, and robust hardware design. A key application of their technology is a comprehensive biosensing platform, designed for diverse health-related purposes such as enhancing consumer wellness, continuous long-term health trend monitoring, patient oversight, early disease detection, optimizing nutrition management, and aiding in the therapeutic management of various chronic conditions.
Unlock all fundamental data
Sign up for FreeUnlock all fundamental data
Sign up for Free